Fundraising FoxNoxilizer
1 known investors
Find your way into Noxilizer
Sign up to see every warm intro you have to Noxilizer
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Noxilizer team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Noxilizer develops a low-temperature, low-pressure nitrogen dioxide (NO₂) sterilization technology used to sterilize prefilled syringes, biologic drug-device combination products, and other sensitive medical products as an alternative to ethylene oxide. It serves pharmaceutical companies, biotech firms, and medical device manufacturers through lab services, R&D studies, regulatory support, IP licensing, and planned contract sterilization.
Investors · 1
Frequently asked questions
- What does Noxilizer do?
- Noxilizer develops a low-temperature, low-pressure nitrogen dioxide (NO₂) sterilization technology used to sterilize prefilled syringes, biologic drug-device combination products, and other sensitive medical products as an alternative to ethylene oxide. It serves pharmaceutical companies, biotech firms, and medical device manufacturers through lab services, R&D studies, regulatory support, IP licensing, and planned contract sterilization.
- Who are Noxilizer's investors?
- Noxilizer's investors include Abell Foundation, Inc..